Category
Bortezomib
CAS Number
862894-96-0
Molecular Formula
C19H22N4O3
Molecular Weight
354.41 g/mol
Synonym

N-[(2S)-1-(3-methylbutanoylamino)-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; (S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; (2S)-N-(3-Methylbutanoyl)-3-phenyl-2-(pyrazin-2- ylformamido)propanamide; Bortezomib Impurity C;N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity 4 is a known impurity or degradation product of Bortezomib. It forms during synthesis, storage, or handling and has a slightly altered chemical structure compared with the active drug. Its presence is closely monitored to maintain the drug’s safety, stability, and therapeutic effectiveness in pharmaceutical formulations.